HTG Molecular Diagnostics has launched the EdgeSeq Immuno-Oncology assay for digitally measuring the mRNA expression of 549 genes implicated in the host immune response to tumors. Automated on the HTG EdgeSeq system, the research-use-only assay couples HTG's proprietary nuclease protection chemistry with next-generation sequencing. With the new assay, researchers can measure the expression level of drug targets, determine tumor infiltrate composition, and assess total immune cell composition using a single section of FFPE tissue, the company said.
Is Genomeweb your business? Claim your listing and attract more leads by adding more content, photos and other business details.
We have more Editor services available on Hotfrog Ireland. You can update your search for Editor by location, keyword or service options.